On October 18, 2025, the 67th (Autumn 2025) National Pharmaceutical Machinery Exposition & 2025 (Autumn) China International ...

Veterans of the biotech business sometimes talk about surviving various “winters” for their industry — periods when funding drops and companies cut jobs or shut down entirely. They’re living through a ...

After months of disruption and speculation, is the global pharmaceutical industry entering a new era? With the White House’s ...

In today’s Pharmaceutical Executive Daily, we cover the FDA’s creation of a new National Priority Voucher Program, the market ...

Biogenesis today launched from stealth, backed by Jack Altman’s Alt Capital. Biogenesis builds an automated feasibility ...

Leverage RWE strategically to build regulator-ready submissions.

Analysts have set 12-month price targets for Krystal Biotech, revealing an average target of $220.78, a high estimate of $255.00, and a low estimate of $166.00. This upward trend is evident, with the ...

The biotech and pharma Industries are growing healthcare solutions for the future. These locations support the industry's ...

Not just any pharmaceutical stock will do, though. They aren't all created equal. Let's discuss two leaders in the industry ...

Brown didn't think anyone would take her serious after leaving the automotive space but it led her to co-found biotech ...

Home to a well-established hub with strong investment and startup activity, discover what makes Cambridge's biotech scene so ...

As Labiotech attented the NLS Days this week, it was the occasion to learn more about the biotech industry in Sweden.